September 21, 2014 8:42 PM ET

Healthcare Equipment and Supplies

Company Overview of Singulex, Inc.

Company Overview

Singulex, Inc. develops and manufactures immunodiagnostic products. It provides immunoassay systems, which includes benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and software to automatically analyze data and display detailed assay reports. The company also offers molecule counting products; ultrasensitive immunoassays, such as inflammation, cardiovascular, neurology, oncology, metabolism, and toxicity; SgxHD for cardiovascular monitoring; and custom services and support, such as sample testing, assay development, and antibody derivatization. Singulex, Inc. was formerly known as BioProfile Corporation and changed its name to Singulex, ...

1650 Harbor Bay Parkway

Suite 200

Alameda, CA 94502

United States

Founded in 1997

177 Employees

Phone:

510-995-9000

Fax:

510-995-9092

Key Executives for Singulex, Inc.

Chief Executive Officer
Age: 49
Chief Financial Officer and Principal Accounting Officer
Age: 45
Chief Commercial Officer and Senior Vice President of Sales & Marketing
Age: 62
Chief Medical Officer
Vice President of Business Development
Compensation as of Fiscal Year 2014.

Singulex, Inc. Key Developments

Singulex, Inc. Provides Development Progress with Ultrasensitive Sgx Clarity System

Singulex, Inc. outlined development progress toward commercializing, as early as 2016, an ultrasensitive immunoassay system for the in vitro diagnostics (IVD) market. Utilizing Singulex's proprietary SMC technology, the fully-automated Sgx Clarity System is designed to detect low abundance biomarkers at levels down to femtograms/mL. The company's novel immunochemistry technology will be introduced to the American Association for Clinical Chemistry at the Annual Meeting taking place in Chicago from July 27 to 31, 2014.

Singulex Appoints Peter Heseltine as Chief Medical Officer

Singulex, Inc. announced the appointment of Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer. At Singulex, Dr. Heseltine will have overall responsibility for clinical strategy, including scientific and medical affairs.

Sony DADC and Singulex Announce Strategic Partnership for Proprietary Detection Vessels

Sony DADC Austria AG and Singulex, Inc. announced an exclusive multi-year supply agreement covering customized detection vessels designed and manufactured by Sony DADC BioSciences for the Sgx Clarity(TM) System, an ultrasensitive in vitro diagnostics (IVD) platform currently in development. Utilizing Singulex's proprietary single molecule counting (SMC(TM)) technology, the fully-automated Sgx Clarity(TM) System is expected to detect low abundance biomarkers at levels down to femtograms/mL. The customized detection vessel is manufactured as a one-piece, molded microtiter plate that has high optical transparency, high purity and low fluorescence, all critical properties required for achieving the ultrasensitivity of the Sgx Clarity(TM) System. The detection vessel is manufactured in Sony's clean-room environment under ISO 13485 and specially packaged in order to maintain product integrity and maximize cleanliness.

Similar Private Companies By Industry

Company Name Region
6SensorLabs, Inc. United States
MindFrame Inc. United States
Interplex Medical, LLC United States
Siemens Healthcare Diagnostics, Inc. United States
AnaZyme United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Singulex, Inc., please visit www.singulex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.